0001140361-15-012986.txt : 20150323
0001140361-15-012986.hdr.sgml : 20150323
20150323203155
ACCESSION NUMBER: 0001140361-15-012986
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150319
FILED AS OF DATE: 20150323
DATE AS OF CHANGE: 20150323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Sunil
CENTRAL INDEX KEY: 0001503062
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 15720299
MAIL ADDRESS:
STREET 1: 11085 NORTH TORREY PINES RD., SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc1.xml
FORM 4
X0306
4
2015-03-19
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001503062
Patel Sunil
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
See Remarks
Common Stock
2015-03-19
4
M
0
3335
3.42
A
23335
D
Common Stock
2015-03-19
4
S
0
3335
27.3422
D
20000
D
Common Stock
2015-03-20
4
M
0
14665
3.42
A
34665
D
Common Stock
2015-03-20
4
S
0
14665
27.8584
D
20000
D
Stock Option (Right to Buy)
3.42
2015-03-19
4
M
0
3335
0.00
D
2019-07-30
Common Stock
3335
116260
D
Stock Option (Right to Buy)
3.42
2015-03-20
4
M
0
14665
0.00
D
2019-07-30
Common Stock
14665
101595
D
Includes 20,000 Restricted Stock Units.
Transaction executed in multiple trades at prices ranging from $27.34 to $27.3701 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Transaction executed in multiple trades at prices ranging from $27.66 to $27.99 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The option is fully vested and exercisable.
Chief Financial Officer and Senior Vice President, Corporate Development and Finance
/s/ Alicia J. Hager, Attorney-in-Fact for Sunil Patel
2015-03-23